Low-dose NOAC after COVID-19 hospitalization in patients with high thrombotic risk - PACE-CME

Lowdose NOAC after COVID hospitalization in patients with high thrombotic risk

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Lower stroke risk with DOAC vs. aspirin in subclinical atrial fibrillation
Lower stroke risk with DOAC vs. aspirin in subclinical atrial fibrillation
AHA 2023
Lower stroke risk with DOAC vs. aspirin in subclinical atrial fibrillation
- Jeff Healey, MD
International survey of secondary prevention of CHD
International survey of secondary prevention of CHD
ESC Congress 2023
International survey of secondary prevention of CHD
- John W. McEvoy, MD, PhD
- Joris Holtrop, MD
What is the best antithrombotic treatment post-PCI?
What is the best antithrombotic treatment post-PCI?
ESC Congress 2023
What is the best antithrombotic treatment post-PCI?
- Marco Valgimigli, MD, PhD
Unexpected results after switching from VKA to DOAC in frail older patients with AF
Unexpected results after switching from VKA to DOAC in frail older patients with AF
ESC Congress 2023
Unexpected results after switching from VKA to DOAC in frail older patients with AF
- Linda Joosten, MD